Francis M. Cuss - May 30, 2024 Form 4/A Insider Report for Mural Oncology plc (MURA)

Role
Director
Signature
/s/ Maiken Keson-Brookes, attorney-in-fact for Francis M. Cuss
Stock symbol
MURA
Transactions as of
May 30, 2024
Transactions value $
$0
Form type
4/A
Date filed
6/5/2024, 04:13 PM
Date Of Original Report
Jun 3, 2024
Previous filing
Dec 18, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MURA Stock Option (right to buy) Award $0 +8.46K $0.00 8.46K May 30, 2024 Ordinary Shares 8.46K $3.35 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on May 30, 2024. This option will vest in full upon the earlier of (i) the first anniversary of the date of the grant or (ii) the date of the next Annual Meeting, subject to the reporting person's continued service with the Issuer.
F2 This amendment to Form 4 is being filed solely to correct the price of the derivative security, which was previously reported as being $3.35 due to a scrivener's error.